コンテンツへスキップ
Merck
  • The Neuromodulator Adenosine Regulates Oligodendrocyte Migration at Motor Exit Point Transition Zones.

The Neuromodulator Adenosine Regulates Oligodendrocyte Migration at Motor Exit Point Transition Zones.

Cell reports (2019-04-04)
Laura Fontenas, Taylor G Welsh, Melanie Piller, Patricia Coughenour, Avni V Gandhi, David A Prober, Sarah Kucenas
要旨

During development, oligodendrocyte progenitor cells (OPCs) migrate extensively throughout the spinal cord. However, their migration is restricted at transition zones (TZs). At these specialized locations, unique glial cells in both zebrafish and mice play a role in preventing peripheral OPC migration, but the mechanisms of this regulation are not understood. To elucidate the mechanisms that mediate OPC segregation at motor exit point (MEP) TZs, we performed an unbiased small-molecule screen. Using chemical screening and in vivo imaging, we discovered that inhibition of A2a adenosine receptors (ARs) causes ectopic OPC migration out of the spinal cord. We provide in vivo evidence that neuromodulation, partially mediated by adenosine, influences OPC migration specifically at the MEP TZ. This work opens exciting possibilities for understanding how OPCs reach their final destinations during development and identifies mechanisms that could promote their migration in disease.

材料
製品番号
ブランド
製品内容

Roche
抗-ジゴキシゲニン-AP、Fabフラグメント, from sheep
Sigma-Aldrich
臭化パンクロニウム
Sigma-Aldrich
Adenosine A2A Receptor Agonist I, CGS 21680, Hydrochloride
Sigma-Aldrich
MRS 1754 水和物, ≥98% (HPLC), solid
Sigma-Aldrich
AG 1478, InSolution, ≥98%, inhibitor EGF receptor tyrosine kinase